SPALLUTO, Giampiero
 Distribuzione geografica
Continente #
NA - Nord America 4.109
AS - Asia 2.034
EU - Europa 1.045
SA - Sud America 286
AF - Africa 35
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 3
Totale 7.531
Nazione #
US - Stati Uniti d'America 3.963
SG - Singapore 674
CN - Cina 598
BR - Brasile 209
VN - Vietnam 200
UA - Ucraina 187
DE - Germania 186
HK - Hong Kong 166
TR - Turchia 159
GB - Regno Unito 142
IT - Italia 139
SE - Svezia 85
FI - Finlandia 73
FR - Francia 67
CA - Canada 58
IN - India 57
RU - Federazione Russa 50
JP - Giappone 47
BD - Bangladesh 39
MX - Messico 33
AR - Argentina 30
PL - Polonia 27
ES - Italia 21
ZA - Sudafrica 18
AT - Austria 15
IQ - Iraq 15
NL - Olanda 15
EC - Ecuador 11
CO - Colombia 9
JM - Giamaica 8
LT - Lituania 8
SA - Arabia Saudita 8
SV - El Salvador 8
TT - Trinidad e Tobago 8
BE - Belgio 7
GP - Guadalupe 7
IL - Israele 7
PK - Pakistan 7
VE - Venezuela 7
CZ - Repubblica Ceca 6
ID - Indonesia 6
JO - Giordania 6
MA - Marocco 6
BO - Bolivia 5
HN - Honduras 5
IE - Irlanda 5
NI - Nicaragua 5
PE - Perù 5
SC - Seychelles 5
AE - Emirati Arabi Uniti 4
CR - Costa Rica 4
GT - Guatemala 4
PR - Porto Rico 4
PY - Paraguay 4
TW - Taiwan 4
UZ - Uzbekistan 4
AZ - Azerbaigian 3
IR - Iran 3
MY - Malesia 3
NP - Nepal 3
PH - Filippine 3
PS - Palestinian Territory 3
AL - Albania 2
AU - Australia 2
CL - Cile 2
CW - ???statistics.table.value.countryCode.CW??? 2
CY - Cipro 2
GY - Guiana 2
KZ - Kazakistan 2
LB - Libano 2
MN - Mongolia 2
RS - Serbia 2
TN - Tunisia 2
AM - Armenia 1
BG - Bulgaria 1
BY - Bielorussia 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
HR - Croazia 1
KE - Kenya 1
KG - Kirghizistan 1
KR - Corea 1
KW - Kuwait 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SI - Slovenia 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TZ - Tanzania 1
UY - Uruguay 1
Totale 7.514
Città #
Singapore 436
Ashburn 380
Woodbridge 272
San Jose 268
Chandler 251
Houston 228
Fairfield 204
Beijing 198
Jacksonville 198
Hong Kong 166
Ann Arbor 164
Santa Clara 159
Council Bluffs 154
Nanjing 87
Wilmington 85
Dallas 84
Izmir 76
Los Angeles 70
Ho Chi Minh City 67
Seattle 67
New York 54
Cambridge 53
Munich 49
Hanoi 47
Princeton 46
Tokyo 37
Boardman 35
Dearborn 35
São Paulo 28
Lauterbourg 27
Shanghai 26
London 24
Orem 24
Buffalo 23
Phoenix 23
Brooklyn 22
Milan 22
Shenyang 22
Turku 21
Nanchang 19
San Diego 19
Warsaw 19
Mexico City 18
Hefei 17
Tianjin 17
Frankfurt am Main 16
Toronto 16
Washington 15
Addison 14
Chennai 14
Falkenstein 14
Helsinki 14
San Mateo 14
Vienna 14
Atlanta 13
Changsha 13
San Francisco 13
Rome 12
Jiaxing 11
Philadelphia 11
Chicago 10
Da Nang 10
Hebei 10
Montreal 10
Jinan 9
Johannesburg 9
Moscow 9
Queens 9
Rio de Janeiro 9
Zhengzhou 9
Bremen 8
Denver 8
Falls Church 8
Kunming 8
Manchester 8
Mumbai 8
Naples 8
Norwalk 8
Ottawa 8
Poplar 8
Amsterdam 7
Boston 7
Ningbo 7
Taizhou 7
Amman 6
Brussels 6
Charlotte 6
Ferrara 6
Haiphong 6
Louisville 6
San Salvador 6
Tampa 6
Cleveland 5
Florence 5
Managua 5
North Bergen 5
Pasadena 5
Verona 5
Ankara 4
Baghdad 4
Totale 4.833
Nome #
4-Isopropyl-2-oxazolin-5-one anion as a new convenient formyl anion equivalent for conjugate addition and aldol reactions 353
A formal total synthesis (±)-forskolin through [3+2] nitrile oxide cycloaddition chemistry 313
[H-3]MRE 3008F20: A novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors 290
4-Isopropyl-2-oxazolin-5-one anion as masked umpoled synthon for both formyl and hydroxycarbonyl anions: generation, reactivity and synthetic applications 287
Changes in cortical ACh and GABA outflow during morphine withdrawal involve alpha-1 and alpha-2 receptors 272
5‐Hydroxytryptamine‐mediated effects of nicotine on endogenous GABA efflux from guinea‐pig cortical slices 266
Enantioselective synthesis of (-)-meroquinene through tandem Michael reaction methodology 262
Mastering β-Keto Esters 251
Synthesis, in vitro antiproliferative activity, and DNA-binding properties of hybrid molecules containing pyrrolo[2,1-c][1,4] benzodiazepine and minor-groove-binding oligopyrrole carriers 244
Alpha-2 adrenoreceptor-mediated decrease in gamma-aminobutyric acid outflow in cortical slices and synaptosomes during morphine tolerance 241
7-substituted-5-amino-2-(furyl)-pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: importance of modifications at the side chain on the activity and solubility. 236
[3H]-MRE 3008-F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors. 236
Effect of acute and subchronic nicotine treatment on cortical efflux of [3H]‐d‐aspartate and endogenous GABA in freely moving guinea‐pigs 235
A new synthetic approach to indazole synthesis 231
Alpha-1 adrenoreceptor-mediated increase in ACh release in brain slices during morphine tolerance 229
7-sobstituted-5-amino-2-(furyl)-pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonist: importance of modifications at the side chain on the activity and solubility. 223
[3H]MRE3008-F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors. 220
New potent and selective human adenosine A3 receptor antagonists 198
Generation and cycloaddition reactions of 3-substituted-2-nitro-1,3- dienes 197
Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells. 197
Resolution of a CPzI precursor, synthesis and biological evaluation of (+) and (-)-N-Boc-CPzI: A further validation of the relationship between chemical solvolytic stability and cytotoxicity 191
Fluorosulfonyl- and bis-(beta-chloroethyl)amino-phenylamino functionalized pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives: Irreversible antagonists at the human A(3) adenosine receptor and molecular modeling studies 158
Pharmacological and biochemical characterization of A3 adenosine receptor in Jurkat T cells. 153
Pyrazolo [4,3-E]1,2,4-triazolo[1,5-c]pyrimidine derivates a new class of potent and selective human A3 adenosine receptor antagonists. 152
Synthesis and molecular investigation of new pyrazolo[4,3-e]1,2,4,-triazolo[1,5-c]pyrimidine derivates as human A3 adenosine receptor antagonists. 141
Substituted 6-amino-thiouracils as new P2Y(12) receptor antagonists 138
Synthesis and molecular investigation of new pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivates as human A3 adenosine receptor antagonists. 138
Synthesis and pharmacological characterization of [3H]-MRE3008F20: the first radioligand antagonist for the human A3 adenosine receptors. 132
Synthesis, biological properties and molecular modelling investigation of the first potent, selective and water soluble human A3 adenosine receptor antagonist. 132
Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives: A new pharmacological tool for the characterization of the human A(3) adenosine receptor 130
Synthesis, binding and thermodynamic studies of new highly selective A2A adenosine receptor antagonists 130
Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]-pyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists 129
Synthesis and preliminary biological evaluation of [3H]-MRE 3008F20: the first high affinity radioligand antagonist for the human A3 adenosine receptors 127
Pyrazolo[4,3-e]1,2,4-triazolo[1,5]pyrimidine derivates as irreversible antagonists at the human A3 adenosine receptor 126
Pyrazolo-triazolo-pyrimidine as human A3 adenosine receptor antagonists: influence of the substitutent at N8 pyrazole nucleus. 121
Pyrazolo-triazolo-pyrimidine derivates as adenosine receptor ligands: a search for A2B adenosine receptor antagonists. 119
Pyrazolo [4,3-E]1,2,4-trazolo[1,5-c]pyrimidine derivatives a new class of potent and selective human A3 adenosine receptor antagonists 116
Second generation of A2A adenosine receptor antagonist: synthesis and biological evaluation 114
An efficient synthesis of 4-oxo-2,5-hexadienoates via Δ2-isoxazoline intermediates 103
Totale 7.531
Categoria #
all - tutte 31.773
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.773


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022298 0 0 0 0 20 11 11 22 17 33 46 138
2022/2023488 41 44 6 78 82 74 16 50 63 2 18 14
2023/2024198 22 26 10 5 27 26 8 12 5 3 1 53
2024/2025902 15 24 66 54 98 74 28 49 115 116 129 134
2025/20262.585 288 91 220 380 397 188 229 108 259 289 94 42
2026/2027847 71 159 284 285 48 0 0 0 0 0 0 0
Totale 7.531